c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis
Open Access
- 15 February 2002
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 21 (4) , 514-524
- https://doi.org/10.1093/emboj/21.4.514
Abstract
The mechanism by which the ubiquitously expressed Src family kinases regulate mitogenesis is not well understood. Here we report that cytoplasmic tyrosine kinase c‐Abl is an important effector of c‐Src for PDGF‐ and serum‐induced DNA synthesis. Inactivation of cytoplasmic c‐Abl by the kinase‐ inactive Abl‐PP‐K− (AblP242E/P249E/K290M) or by microinjection of Abl neutralizing antibodies inhibited mitogenesis. The kinase‐inactive SrcK295M induced a G1 block that was overcome by the constitutively active Abl‐PP (AblP242E/P249E). Conversely, the inhibitory effect of Abl‐PP‐K− was not compensated by Src. c‐Src‐induced c‐Abl activation involves phosphorylation of Y245 and Y412, two residues required for c‐Abl mitogenic function. Finally, we found that p53 inactivation and c‐ myc expression, two cell cycle events regulated by Src during mitogenesis, also implied c‐Abl: c‐Abl function was dispensable in cells deficient in active p53 and inhibition of c‐Abl reduced mitogen‐induced c‐ myc expression. These data identify a novel function of cytoplasmic c‐Abl in the signalling pathways regulating growth factor‐induced c‐ myc expression and we propose the existence of a tyro sine kinase signalling cascade (PDGFR/c‐Src/c‐Abl) important for mitogenesis.Keywords
This publication has 44 references indexed in Scilit:
- Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinaseOncogene, 2001
- STAM2, a new member of the STAM family, binding to the Janus kinasesFEBS Letters, 2000
- No requirement for Src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigenOncogene, 2000
- Anti-apoptotic activity of p53 maps to the COOH-terminal domain and is retained in a highly oncogenic natural mutantOncogene, 1999
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- An intramolecular SH3-domain interaction regulates c-Abl activityNature Genetics, 1998
- Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and agingOncogene, 1997
- Requirement for c-Src Catalytic Activity and the SH3 Domain in Platelet-derived Growth Factor BB and Epidermal Growth Factor Mitogenic SignalingJournal of Biological Chemistry, 1996
- Differential Complementation of Bcr-Abl Point Mutants with c-MycScience, 1994
- Receptor Protein-Tyrosine Kinases and Their Signal Transduction PathwaysAnnual Review of Cell and Developmental Biology, 1994